We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Eureka

News List

Sanofi to license multiple myeloma target domain from Eureka and MSK pharmaceutical-technology
July 08, 2021
Sanofi has signed a licence agreement with Eureka Therapeutics and Memorial Sloan Kettering Cancer Center (MSK) for non-CAR use of a new human binding domain for the potential treatment of multiple myeloma.
Eureka initiates trial to evaluate ET140203 ARTEMIS T Cell Therapy in HCC pharmaceutical-business-review
October 10, 2020
Eureka Therapeutics, Inc. announced the Company has initiated a Phase I/II clinical trial of its ET140203 ARTEMIS T cell therapy in adult patients with hepatocellular carcinoma (HCC), the predominant type of liver cancer.